Sema4 Holdings Corp

Sema4 Holdings Corp (NASDAQ: SMFR) was formerly known as CM Life Sciences Inc. It is a health intelligence company. SMFR focuses on advanced healthcare using data-driven insights.

Investment Highlights – Watch at USD 9.33

• The Company made a loss from operations in Q2 FY2021.
• Its cash declined from USD 1.09 million in FY2020 to USD 0.17 million in H1 FY2021.
• On the liquidity front, SMFR’s current ratio in Q2 FY2021 has been much lower than 1.00x.
• From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 10.72. Hence, there could be a correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and reduced liquidity, we have given a "WATCH" stance on Sema4 Holdings Corp at the closing market price of USD 9.33 (as of 23 August 2021). 

T2 Biosystems Inc

T2 Biosystems Inc (NASDAQ: TTOO) is a diagnostics company. It uses its T2MR technology and detects pathogens rapidly.

Investment Highlights – Watch at USD 0.91

• The Company made a net loss in H1 FY2021.
• TTOO is dependent on external funding to run its operation.
• On the profitability front, TTOO’s gross margin in Q2 FY2021 has been much lower than the industry median of 85.4%.
• On the liquidity front, TTOO’s current ratio in Q2 FY2021 has been lower than the industry median of 7.43x.
• On the leverage front, TTOO’s debt/equity ratio in Q2 FY2021 has been much higher than the industry median of 0.00x.
• From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 1.00, indicating a potential correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and its dependence on external funding, we have given a "WATCH" stance on T2 Biosystems Inc at the closing market price of USD 0.91 (as of 23 August 2021).

*The reference data in this report has been partly sourced from Refinitiv.

Disclaimer

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.